| Excerpt | Relevance | Reference |
|---|
| " The hypothesis of the present study was that treatment with the transglutaminase inhibitor, cystamine, would inhibit the development of pulmonary arterial remodeling, pulmonary hypertension, and right ventricular hypertrophy." | 8.02 | Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats. ( Aalling, M; Andersen, CU; Markvardsen, LK; Mogensen, S; Pinilla, E; Prat-Duran, J; Simonsen, U; Sønderskov, LD; Wandall-Frostholm, C, 2021) |
| " The hypothesis of the present study was that treatment with the transglutaminase inhibitor, cystamine, would inhibit the development of pulmonary arterial remodeling, pulmonary hypertension, and right ventricular hypertrophy." | 4.02 | Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats. ( Aalling, M; Andersen, CU; Markvardsen, LK; Mogensen, S; Pinilla, E; Prat-Duran, J; Simonsen, U; Sønderskov, LD; Wandall-Frostholm, C, 2021) |